BARD1 and breast carcinoma: Case–control studies have found a low to moderate association between breast cancer and pathogenic and likely pathogenic (P/LP) variants in the BARD1 gene, with a prevalence range of 0.1% to 0.51% in patients with breast cancer [1,3,28].